|
⚲
|
| Keyboard |
| ProQuest Management LLC
✚
|
|
|---|---|
| CRD # | 127747 |
| SEC # | 801-62295 |
| CIK # | 0001379010, 0001674772 |
| AUM | |
| Employees | |
| Phone | 615-370-4242 |
| Address | 9003 Overlook Blvd Brentwood, TN 37027 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 57 | 25.1 |
| By Discretionary | ||
| Discretionary | 57 | 25.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 57 | 25.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 25.1 | |
| Total | 57 | 25.1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001379010] | |
| 4 | [0001379010] | |
| 3 | [0001674772] | |
| 4 | [0001674772] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ProQuest Investments IV LP | |
| ProQuest Associates IV LLC | |
| Moorin Jay | |
| Schreiber Alain | |
| Eagle Pharmaceuticals Inc | |
| ProQuest Financial LLC | |
| ProQuest Management LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 149,107 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 149,107 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-05-15 | Other | 3,584,087 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 3,120 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 10,000 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 2,340 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Sell | 51,219 | $88.34 | 4,524,686 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $0.90 | 2,106 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $4.04 | 9,454 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Stock Option (right to buy) · derivative
|
2017-04-25 | Option exercise | 9,360 | $0.00 | |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 2,340 | $8.78 | 20,545 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 10,000 | $46.09 | 460,900 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Sell | 2,961 | $89.09 | 263,795 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 9,360 | $12.67 | 118,591 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 3,120 | $4.42 | 13,790 |
|
Eagle Pharmaceuticals Inc EGRX
Common Stock $0.001 par value
|
2017-04-25 | Option exercise | 20,000 | $59.31 | 1,186,200 |
| showing 20 of 117 most recent transactions | |||||